Opendata, web and dolomites

Embryospin

Increasing IVF success rate through the first magnetic resonance system for embryonic quantitative analysis at the cell scale

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Embryospin project word cloud

Explore the words cloud of the Embryospin project. It provides you a very rough idea of what is the project "Embryospin" about.

labels    belgium    fertilization    morphological    microscopic    performed    purely    opportunity    commercialization    nuclear    microscope    infertile    2021    germany    customers    family    screen    beginning    hour    magnetic    fold    ivf    screening    micronmr    technique    performances    launch    bench    turn    radically    plan    patent    resonance    starting    refine    viability    embryospin    annaida    business    qualitative    pricing    surprisingly    healthcare    biopsy    pave    pad    nmr    coupled    france    validation    prospective    device    performs    rate    rates    embryos    market    frustratingly    strategy    fulfil    desire    embryo    technologies    vitro    tissue    attract    improvement    filed    validate    national    poised    laboratories    sensor    33    despite    invasive    scaling    investment    today    costly    optical    decades    commercialize    couples    techniques    chemical    savings    engineering    suitable    subsidize    preparation    disposable    microns    insights    provides   

Project "Embryospin" data sheet

The following table provides information about the project.

Coordinator
ANNAIDA TECHNOLOGIES SARL 

Organization address
address: AVENUE LOUIS-RUCHONNET 26
city: LAUSANNE
postcode: 1003
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website https://www.linkedin.com/company/annaida-technologies/about/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ANNAIDA TECHNOLOGIES SARL CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

Today 1 out of 6 couples turn to the In Vitro Fertilization (IVF) technique to fulfil their desire of starting a family. Despite decades of research and high costs, the success rate of IVF remains frustratingly low (33%). A key factor in determining the IVF success is the embryo screening to determine viability. Surprisingly enough, embryo selection is currently performed through optical analysis with a microscope, that is a purely morphological, qualitative assessment that provides no reliable insights on embryo viability. Other available techniques are costly and invasive, since require the use of chemical labels or even a tissue biopsy. Annaida Technologies has developed Embryospin, a patent-filed device that performs microscopic Nuclear Magnetic Resonance (microNMR) at a scale of 100 microns, a 10-fold improvement over existing technologies. Annaida will develop and commercialize an NMR bench-top device, coupled with a disposable microNMR sensor able to screen up to 10 embryos in less than an hour. The technology is poised to radically increase the IVF laboratories’ success rates, thus ensuring significant savings to infertile couples and also to National Healthcare Systems that subsidize IVF costs, like France, Belgium and Germany. The Phase 1 project will be a launch pad for the future commercialization of the system, enabling to validate the Embryospin performances and the market opportunity, determine the most suitable pricing strategy, and refine the business plan to attract the future investment needed for scaling up the production. The following step will be to proceed with system engineering and preparation to the in-field validation (Phase 2) together with large prospective customers, which will pave the way to the beginning of the commercialization phase in 2021.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYOSPIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYOSPIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

MycoProScale (2020)

MycoProScale – Creating global markets with a unique large-scale Mycorrhiza production method

Read More